{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:44:55Z","timestamp":1790963095739,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1097\/01.mbc.0000256022.01900.c2","type":"journal-article","created":{"date-parts":[[2006,12,15]],"date-time":"2006-12-15T04:04:32Z","timestamp":1166155472000},"page":"21-28","source":"Crossref","is-referenced-by-count":35,"title":["The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus"],"prefix":"10.1097","volume":"18","author":[{"given":"Eelco W","family":"Meesters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hjalmar","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri MH","family":"Spronk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karly","family":"Hamulyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rosing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajda T","family":"Rowshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ineke JM","family":"ten Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90431-9","article-title":"The bimodal mortality pattern of systemic lupus erythematosus","volume":"60","author":"Urowitz","year":"1976","journal-title":"Am J Med"},{"key":"R2-4-20210203","first-page":"1259","article-title":"Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death","volume":"22","author":"Abu-Shakra","year":"1995","journal-title":"J Rheumatol"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMp038168","article-title":"Systemic lupus erythematosus and accelerated atherosclerosis","volume":"349","author":"Hahn","year":"2003","journal-title":"N Engl J Med"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005792-199905000-00003","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus","volume":"78","author":"Cervera","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"R6-4-20210203","first-page":"909","article-title":"Duplex study of the carotid and femoral arteries of patients with systemic lupus erythematosus: a controlled study","volume":"31","author":"Wolak","year":"2004","journal-title":"J Rheumatol"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"524","DOI":"10.7326\/0003-4819-106-4-524","article-title":"The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level","volume":"106","author":"Petri","year":"1987","journal-title":"Ann Intern Med"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0002-9343(96)00335-X","article-title":"The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases","volume":"101","author":"Merkel","year":"1996","journal-title":"Am J Med"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood-2003-11-4085","article-title":"The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus","volume":"104","author":"Brouwer","year":"2004","journal-title":"Blood"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa022157","article-title":"An association between atherosclerosis and venous thrombosis","volume":"348","author":"Prandoni","year":"2003","journal-title":"N Engl J Med"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2003.08.029","article-title":"Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction","volume":"171","author":"Bennet","year":"2003","journal-title":"Atherosclerosis"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2003-09-3198","article-title":"Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity","volume":"103","author":"Rajagopalan","year":"2004","journal-title":"Blood"},{"key":"R16-4-20210203","first-page":"1400","article-title":"The endothelium and coagulopathy in systemic lupus erythematosus: hyperhomocysteinemia as a developing risk factor","volume":"30","author":"Fijnheer","year":"2003","journal-title":"J Rheumatol"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0008-6363(02)00857-X","article-title":"Infection and inflammation and the coagulation system","volume":"60","author":"Levi","year":"2003","journal-title":"Cardiovasc Res"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/bies.10360","article-title":"The blood coagulation system as a molecular machine","volume":"25","author":"Spronk","year":"2003","journal-title":"Bioessays"},{"key":"R19-4-20210203","first-page":"1479","article-title":"Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia","volume":"30","author":"Tam","year":"2003","journal-title":"J Rheumatol"},{"key":"R20-4-20210203","first-page":"549","article-title":"Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE","volume":"10","author":"Bencivelli","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"8852","DOI":"10.1021\/bi002500a","article-title":"Purified protein S contains multimeric forms with increased APC-independent anticoagulant activity","volume":"40","author":"Sere","year":"2001","journal-title":"Biochemistry"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0037-1613029","article-title":"Effects of (pre-)analytical variables on activated protein C resistance determined via a thrombin generation-based assay","volume":"87","author":"Curvers","year":"2002","journal-title":"Thromb Haemost"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00001721-199701000-00006","article-title":"Effect of activated protein C on thrombin generation and on the thrombin potential in plasma of normal and APC-resistant individuals","volume":"8","author":"Nicolaes","year":"1997","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1055\/s-0037-1614172","article-title":"An assay to quantify the two plasma isoforms of factor V","volume":"84","author":"Hoekema","year":"2000","journal-title":"Thromb Haemost"},{"key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(96)03032-2","article-title":"Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus","volume":"348","author":"Petri","year":"1996","journal-title":"Lancet"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1073\/pnas.78.4.2512","article-title":"High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein","volume":"78","author":"Dahlback","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000463131","article-title":"C4b-binding protein, a regulatory component of the classical pathway of complement, is an acute-phase protein and is elevated in systemic lupus erythematosus","volume":"7","author":"Barnum","year":"1990","journal-title":"Complement Inflamm"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2141.1999.01302.x","article-title":"Acquired APC resistance and oral contraceptives: differences between two functional tests","volume":"105","author":"Curvers","year":"1999","journal-title":"Br J Haematol"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/rheumatology\/33.12.1112","article-title":"Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis","volume":"33","author":"Janssen","year":"1994","journal-title":"Br J Rheumatol"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s100670170023","article-title":"Clinical utility of selected disease activity markers in patients with systemic lupus erythematosus","volume":"20","author":"Horak","year":"2001","journal-title":"Clin Rheumatol"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.2741\/1273","article-title":"Soluble adhesion molecule levels, neuropsychiatric lupus and lupus-related damage","volume":"9","author":"Zaccagni","year":"2004","journal-title":"Front Biosci"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V93.4.1271","article-title":"A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis","volume":"93","author":"de Visser","year":"1999","journal-title":"Blood"},{"key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"643","DOI":"10.7326\/0003-4819-130-8-199904200-00004","article-title":"Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism","volume":"130","author":"Rodeghiero","year":"1999","journal-title":"Ann Intern Med"},{"key":"R35-4-20210203","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2003.04443.x","article-title":"Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women","volume":"122","author":"Tans","year":"2003","journal-title":"Br J Haematol"},{"key":"R36-4-20210203","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1160\/TH03-03-0151","article-title":"Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance","volume":"90","author":"Bertolaccini","year":"2003","journal-title":"Thromb Haemost"},{"key":"R37-4-20210203","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1373\/clinchem.2004.043414","article-title":"Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism","volume":"51","author":"Nojima","year":"2005","journal-title":"Clin Chem"},{"key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1182\/blood.V97.4.844","article-title":"Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus","volume":"97","author":"Male","year":"2001","journal-title":"Blood"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00001721-199910000-00002","article-title":"Influence of factor VIII\/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation","volume":"10","author":"De Mitrio","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R40-4-20210203","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ajcp\/111.6.769","article-title":"Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII:c levels","volume":"111","author":"Marcucci","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"R41-4-20210203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-9560-2-12","article-title":"Blood coagulation and the risk of atherothrombosis: a complex relationship [open access]","volume":"2","author":"Spronk","year":"2004","journal-title":"Thromb J"},{"key":"R42-4-20210203","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1191\/0961203302lu256oa","article-title":"Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus","volume":"11","author":"Munoz-Rodriguez","year":"2002","journal-title":"Lupus"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mbc.0000256022.01900.c2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:57:40Z","timestamp":1786039060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200701000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000256022.01900.c2","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}